Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Black Dragon |
Description | N/A |
Keywords | N/A |
WebSite | www.bd-pharma.com |
Host IP | 67.202.70.61 |
Location | Chicago, Illinois, United States |
Site | Rank |
US$30,286
Last updated: May 1, 2021
Bd-pharma.com has global traffic rank of 1,691,479. Bd-pharma.com has an estimated worth of US$ 30,286, based on its estimated Ads revenue. Bd-pharma.com receives approximately 1,843 unique visitors each day. Its web server is located in Chicago, Illinois, United States, with IP address 67.202.70.61. According to SiteAdvisor, bd-pharma.com is safe to visit. |
Purchase/Sale Value | US$30,286 |
Daily Ads Revenue | US$16 |
Monthly Ads Revenue | US$497 |
Yearly Ads Revenue | US$6,057 |
Daily Unique Visitors | 1,843 |
Note: All traffic and earnings values are estimates. |
Global Rank | 1,691,479 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
bd-pharma.com | A | 14399 | IP: 67.202.70.61 |
bd-pharma.com | MX | 14399 | Priority: 0 Target: bd-pharma.com. |
bd-pharma.com | NS | 21599 | Target: ns1.tanpixel.com. |
bd-pharma.com | NS | 21599 | Target: ns2.tanpixel.com. |
bd-pharma.com | TXT | 14399 | TXT: v=spf1 ip4:50.31.98.110 +a +mx ~all |
bd-pharma.com | SOA | 21599 | MNAME: ns1.tanpixel.com. RNAME: justin.bigscoots.com. Serial: 2021050100 Refresh: 3600 Retry: 7200 Expire: 1209600 Minimum TTL: 86400 |
HTTP/1.1 200 OK Connection: Keep-Alive Content-Type: text/html Last-Modified: Sun, 12 Apr 2020 10:08:44 GMT Accept-Ranges: bytes Content-Length: 8076 Date: Sat, 01 May 2021 18:17:27 GMT Server: LiteSpeed |
Domain Name: BD-PHARMA.COM Registry Domain ID: 2277550390_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.wildwestdomains.com Registrar URL: http://www.wildwestdomains.com Updated Date: 2018-09-08T18:58:45Z Creation Date: 2018-06-21T16:38:18Z Registry Expiry Date: 2023-06-21T16:38:18Z Registrar: Wild West Domains, LLC Registrar IANA ID: 440 Registrar Abuse Contact Email: abuse@wildwestdomains.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.TANPIXEL.COM Name Server: NS2.TANPIXEL.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: bd-pharma.com Registry Domain ID: 2277550390_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.wildwestdomains.com Registrar URL: http://www.wildwestdomains.com Updated Date: 2019-05-27T09:11:19Z Creation Date: 2018-06-21T11:38:18Z Registrar Registration Expiration Date: 2023-06-21T11:38:18Z Registrar: Wild West Domains, LLC Registrar IANA ID: 440 Registrar Abuse Contact Email: abuse@wildwestdomains.com Registrar Abuse Contact Phone: +1.4806242505 Reseller: Domains Priced Right Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited Domain Status: clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited Domain Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited Registrant Organization: Registrant State/Province: Beirut Registrant Country: LB Registrant Email: Select Contact Domain Holder link at https://www.secureserver.net/whois?plid=1387&domain=bd-pharma.com Tech Email: Select Contact Domain Holder link at https://www.secureserver.net/whois?plid=1387&domain=bd-pharma.com Admin Email: Select Contact Domain Holder link at https://www.secureserver.net/whois?plid=1387&domain=bd-pharma.com Name Server: NS1.TANPIXEL.COM Name Server: NS2.TANPIXEL.COM DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ -status-codes-2014-06-16-en without notice. |